MedTrace Logo

Reducing the Duration of Untreated Psychosis in the United States

NCT03369730 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 94

Last updated 2021-12-14

No results posted yet for this study

Summary

The goal of this project is to investigate whether a systematic screening approach for individuals with first episode psychosis (FEP) can substantially reduce Duration of Untreated Psychosis (DUP). The study team will evaluate the feasibility of screening a consecutive help-seeking population entering mental health services in order to facilitate early identification of FEP cases, rapid referral to specialty care and engagement in treatment.

Conditions

  • First Episode Psychosis (FEP)
  • At Risk Mental State (ARMS)

Sponsors & Collaborators

Principal Investigators

  • Yulia Landa, PsyD, MS · Icahn School of Medicine at Mount Sinai

Eligibility

Min Age
12 Years
Max Age
30 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-02-19
Primary Completion
2021-09-15
Completion
2021-09-15

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03369730 on ClinicalTrials.gov